Further to investigate this, we analyzed the immunohistochemical expression of citrullinated peptides (as detected by F95 antibody) and the PAD2 and PAD4 enzymes in baseline RA samples obtained before initiation of treatment, as compared with healthy synovial biopsies. The gene discussed is PADI4; the disease is rheumatoid arthritis.